Harvard Catalyst Profiles
Contact, publication, and social network information about Harvard faculty and fellows.
Home
About
Overview
Open Source Software
Help
History (1)
Vandetanib for the treatment of medullary thyroid cancer.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Vandetanib for the treatment of medullary thyroid cancer.
Chau NG, Haddad RI. Vandetanib for the treatment of medullary thyroid cancer. Clin Cancer Res. 2013 Feb 01; 19(3):524-9.
View in:
PubMed
subject areas
Antineoplastic Agents
Carcinoma, Neuroendocrine
Clinical Trials as Topic
Humans
Piperidines
Protein Kinase Inhibitors
Quinazolines
Thyroid Neoplasms
Treatment Outcome
authors with profiles
Robert I. Haddad, M.D.